Is Labcorp (LH) overvalued or fairly valued?

MarketChacha shows Labcorp's valuation in context — a forward P/E of about 14.4, a price-to-book of about 2.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Labcorp (LH)?

Labcorp last traded at $279.71 (+0.1% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Labcorp

LH · NYSE · Healthcare · United States

$279.71+0.1%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:37 PM

Snapshot

TickerLH

ExchangeNYSE

SectorHealthcare

IndustryDiagnostics & Research

CountryUnited States

Employees71,000

HeadquartersBurlington, United States

Market cap$22.9B

P/B2.6

Volume228.72K

Websitewww.labcorp.com

Filings tracked0

About Labcorp

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.4%
Institutions99.6%
Public & other0.0%

1,405 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.7.86%
Vanguard Capital Management LLC6.56%
Victory Capital Management Inc.5.64%
State Street Corporation4.71%
Vanguard Portfolio Management LLC4.49%
Boston Partners2.89%
Allspring Global Investments Holdings, LLC2.72%
Geode Capital Management, LLC2.67%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $3.8B · EPS 4.61

Est. earnings growth +10.2%

Next fiscal year

Rev $15.4B · EPS 19.41

Est. earnings growth +7.8%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$244.5252-wk range$293.72

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about LH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.